How is brolucizumab administered?
- Brolucizumab is an injectable eye preparation that is administered directly into the vitreous humor of the eye – this is a jelly-like fluid that fills the inside of the eye.
- It is administered by a qualified physician who will numb your eye and eyelids before the procedure.
- Most people only feel slight pressure and little or no pain while the injection is being administered.
- Brolucizumab is administered monthly for the first three months then 8 to 12 weekly thereafter.
Brolucizumab is an injectable eye preparation that is given to treat a particular type of age-related macular degeneration (AMD) called neovascular or wet AMD. It may also be used to treat diabetic macular edema (DME). DME is a leading cause of blindness in adults in developed countries.
Brolucizumab is administered by a qualified physician by injection directly into the vitreous humor of the eye. This is a jelly-like fluid that fills the inside of the eye.
This way of giving medicine is known as "intravitreal" which literally means "inside the eye".
Brolucizumab is initially given once a month (every 25 to 31 days) for the first three doses, then once every 8 to 12 weeks thereafter, depending on response.
Related questions
- Does Beovu help with wet AMD?
- Does Medicare cover Beovu?
- What is brolucizumab used for and how does it work?
Does brolucizumab hurt when it is given?
Before giving the brolucizumab injection, your physician will anesthetize the eye and eyelids using drops, gel, or a small numbing injection so the brolucizumab injection won’t hurt.
Povidone-iodine solution is usually used to clean around the eye and then an eyelid speculum may be used to keep the eyelids open during the procedure.
While you look in a particular direction, the physician will inject the medicine through the white part of the eye with a very small needle. Although you may feel slight pressure, there is little or no pain during the procedure which takes around 10 to 15 minutes.
How does brolucizumab work?
Brolucizumab works by blocking a substance called vascular endothelial growth factor A (VEGF-A).
VEGF-A is a protein that makes blood vessels grow, leaking fluid and blood into the retina, which damages the macula. Brolucizumab binds to the 3 major forms of VEGF-A, blocking their effects and slowing the growth of blood vessels and reducing their permeability, which controls leakage and slows vision loss.
Brolucizumab belongs to the class of medicines called Vascular Endothelial Growth Factor (VEGF) Inhibitors.
References
- Brolucizumab Updated 02/2022. ASHP monograph https://www.drugclasses.com/monograph/brolucizumab.html
- Intravitreal Injections American Society of Retina Specialists. https://www.asrs.org/patients/retinal-diseases/33/intravitreal-injections
Read next
Is Syfovre covered by Medicare?
Medicare Part B covers eye disease treatment Syfovre if you have geographic atrophy (GA) secondary to age-related macular degeneration (AMD). After you meet your Part B deductible, your cost is 20% of the Medicare-approved amount for the drug and services. Check with your Medicare plan for coverage details. Continue reading
What is the difference between Vabysmo and Eylea?
Vabysmo (faricimab) targets vascular endothelial growth factor (VEGF) and angiopoietin-1, whereas Eylea (afibercept) targets VEGF and placental growth factor (P1GF). Both agents are used to treat conditions such as macular degeneration (AMD) and diabetic macular edema and are given by intravitreal injection (into the gel part of the eye). Continue reading
Does Mounjaro cause blurry vision?
Treatment with Mounjaro can lead to rapid improvement in blood sugar levels and may temporarily worsen diabetic retinopathy, which can cause vision changes like blurry vision. Contact your doctor if you notice blurred vision, spots in your field of vision, flashing lights, or a sudden loss of vision while using this treatment. In addition, tell your doctor if you have a history of diabetic retinopathy before you start treatment. Continue reading
Related medical questions
- What’s the difference between Eylea, Eylea HD, and Avastin?
- What are anti-VEGF drugs (VEGF inhibitors)?
- How long does Eylea or Eylea HD take to work?
- Does Eylea and Eylea HD raise blood pressure?
- What is the difference between Eylea and Eylea HD?
- When do the Eylea and Eylea HD patents expire?
- How do Izervay and Syfovre compare?
- Does Medicare cover Eylea injections?
- What is the mechanism of action for Vabysmo?
- How effective is Syfovre for macular degeneration?
- Does Eylea have a biosimilar?
- All Eyes on Ibuprofen: What are 10 Things You Need to Know?
- Xiidra vs. Restasis: Which is better for dry eye?
- What drugs cause bags under eyes?
- What is the difference between Cequa and Restasis?
- Can I use expired neomycin and polymyxin b sulfates, dexamethasone ophthalmic?
- Is pink eye (conjunctivitis) a sign of COVID-19?
- Can Restasis damage your eyes?
- Does Tyrvaya reduce inflammation?
- What Vaccines do I need if I'm over 50?
- What are the differences between Iluvien, Retisert and Yutiq intravitreal implants?
- Poison Ivy
- Pink Eye - what you need to know
- What eye condition is Oxervate used to treat?
- What do I need to know about Medications/Vaccinations before I Travel?
Drug information
Related support groups
- Beovu (4 questions, 4 members)
- Brolucizumab (3 questions, 3 members)
- Macular Degeneration (33 questions, 65 members)
- Eye Conditions (85 questions, 217 members)
- Macular Edema (10 questions, 13 members)